SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 399 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,281,000 | +21.1% | 11,658 | +5.1% | 0.25% | +15.9% |
| Q2 2020 | $1,884,000 | +2445.9% | 11,088 | +33.6% | 0.21% | +2040.0% |
| Q1 2020 | $74,000 | -91.1% | 8,302 | +14.7% | 0.01% | -88.5% |
| Q4 2019 | $827,000 | +240.3% | 7,235 | +154.1% | 0.09% | +248.0% |
| Q3 2019 | $243,000 | +23.4% | 2,847 | 0.0% | 0.02% | +25.0% |
| Q2 2019 | $197,000 | -22.4% | 2,847 | -18.0% | 0.02% | -16.7% |
| Q1 2019 | $254,000 | +28.9% | 3,470 | 0.0% | 0.02% | -11.1% |
| Q4 2018 | $197,000 | – | 3,470 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |